Toxoplasma IgM assay kits recalled over risk of false positive results
Platelia Toxo IgM kits, catalog number 26211, lot 4L0054, are recalled because of a risk of false positive results that could lead to unnecessary medical treatment. 35 kits are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported; the notice states false positives could lead to unnecessary medical treatment and reports no injuries.
Plain-English summary
The Platelia Toxo IgM assay, catalog number 26211, UDI code 03610520005552, batch/lot 4L0054, is being recalled. The kit is a semi-quantitative immunocapture enzyme immunoassay for detecting IgM antibodies to Toxoplasma gondii in human serum, plasma or cord blood. The recall covers 35 kits distributed in California, Colorado, Florida, North Carolina and Nevada.
The recall was issued because of a risk of false positive results that could lead to unnecessary medical treatment. The FDA classified the action as Class II.
Laboratories holding this lot should stop using it and follow the manufacturer's instructions on affected kits and on results already reported.
The recalled product
- Product
- Platelia Toxo IgM Catalog Number 26211 UDI Code: 03610520005552 The Platelia Toxo IgM assay is a semi-quantitative immunocapture enzyme immunoassay kit for the detection of IgM antibodies to Toxoplasma gondii in human serum, plasma or cord blood specimens.
- Manufacturer
- Bio-Rad Laboratories, Inc.
- Affected units
- 35
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Catalog Number: 26211 UDI-DI code: 03610520005552 Batch/Lot Number: 4L0054
Distribution
Related recalls
Same manufacturer · Bio-Rad Laboratories, Inc.
See all →- HighAPLS IgM Diagnostic Reagent Packs Recalled Due to Incorrect Conjugate
FDA (Devices) · 2023-05-17
- HighBioPlex 2200 Anti-CCP Reagent Pack Recalled for Reduced Diagnostic Specificity
FDA (Devices) · 2023-04-19
- HighBioPlex 2200 Anti-CCP Reagent Kit recalled due to reduced test specificity
FDA (Devices) · 2023-04-19
- HighCMV IgM EIA Diagnostic Test Recalled for Increased False Positives
FDA (Devices) · 2022-12-07
- HighBio-Rad Sickle Cell Testing Software CD-ROM Defect Overwrites Custom Settings
FDA (Devices) · 2022-06-08
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11